“…to present the results from the phase I/II study…”
Not “intermediate results”, just “results”
Looks like the Irinotecan trial has finally been concluded (even though treatment may still be ongoing). Let’s see what the quarterly report has to say later today or tomorrow.
ASCO Presentations 2024, page-23
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.010(9.09%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.0¢ | $97.11K | 916.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 318636 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 123446 | 3 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
-0.010 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.0¢ | 10.0¢ | 332353 | ||
| Last updated 15.02pm 04/06/2024 ? | |||||
| SPL (ASX) Chart |